Post Doctoral Scientist- Global Patient Safety Pharmacoepidemiology

at  Lilly

Indianapolis, IN 46204, USA -

Start DateExpiry DateSalaryPosted OnExperienceSkillsTelecommuteSponsor Visa
Immediate08 Nov, 2024Not Specified09 Aug, 2024N/AAdoption,Diabetes,Addition,Man,Collaboration,Decision Making,Infectious Diseases,Cancer,Communication Skills,Natural History,Public Health,EpidemiologyNoNo
Add to Wishlist Apply All Jobs
Required Visa Status:
CitizenGC
US CitizenStudent Visa
H1BCPT
OPTH4 Spouse of H1B
GC Green Card
Employment Type:
Full TimePart Time
PermanentIndependent - 1099
Contract – W2C2H Independent
C2H W2Contract – Corp 2 Corp
Contract to Hire – Corp 2 Corp

Description:

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

ARE YOU LOOKING TO MAKE A SIGNIFICANT CONTRIBUTION TO PUBLIC HEALTH THROUGH THE PRACTICE OF PHARMACOEPIDEMIOLOGY?

We are seeking an ambitious post-doctoral scientist with strong research and communication skills to contribute to a highly visible research project. Your work will support development of scientific capabilities in the Global Patient Safety (GPS) Pharmacoepidemiology (PE) group by building internal expertise with the Target Trial Emulation (TTe) framework. In this role, you will establish comprehensive understanding of the TTe methodology to meaningfully drive adoption of this approach across the enterprise, serving patients and public health by:

  • Accelerating the production of high-quality scientific protocols.
  • Increasing the acceptability of real-world evidence (RWE) for informing patient safety and regulatory decision-making.
  • Substantively contributing to the advancement of pharmacoepidemiologic science used at Lilly.

In addition to work associated with TTe, the Post-Doctoral Scientist will have the opportunity to gain first-hand experience with the following:

  • Leading and/or collaborating on the design, execution, and interpretation of pharmacoepidemiology studies and specialized risk minimization activities.
  • Evaluating safety signals and communicating with global regulatory authorities.
  • Support Risk Management Planning.
  • Authoring external disclosures.
  • Characterizing the natural history of diseases.

Employment for this position will be in-person at Lilly Corporate Center in Indianapolis, Indiana. The Post-Doctoral Scientist will work closely with other members of the PE team, the broader GPS organization, and with cross-functional teams including Clinical Development, Regulatory Affairs, and others.

BASIC QUALIFICATIONS:

  • A PhD or DrPH in epidemiology or other subject with high epidemiologic content

Responsibilities:

  • Accelerating the production of high-quality scientific protocols.
  • Increasing the acceptability of real-world evidence (RWE) for informing patient safety and regulatory decision-making.
  • Substantively contributing to the advancement of pharmacoepidemiologic science used at Lilly


REQUIREMENT SUMMARY

Min:N/AMax:5.0 year(s)

Hospital/Health Care

Pharma / Biotech / Healthcare / Medical / R&D

Health Care

Phd

Proficient

1

Indianapolis, IN 46204, USA